30.05.2025 07:00 | GDR | Block Listing Returns | RNS |
30.05.2025 07:00 | GDR | CE-certification | RNS |
13.05.2025 13:20 | MERC, KEFI, EST | TRADING UPDATES: Eden Research in California backing; Zinc Media award | Alliance |
13.05.2025 07:00 | GDR | CYP2C19-ID Kit used to support expansion | RNS |
02.05.2025 22:05 | ANX, GCL, VRS | TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress | Alliance |
02.05.2025 13:30 | GDR | CYP2C19 ID Kit CE-IVD certification update | RNS |
02.04.2025 16:48 | GDR | Genedrive wins extra grant funding for NHS genetic testing | Alliance |
02.04.2025 07:01 | GDR | Additional grant funding under DEVOTE programme | RNS |
02.04.2025 07:00 | GDR | Receipt of R&D tax credit | RNS |
01.04.2025 07:00 | GDR | Result of RetailBook Offer | RNS |
27.03.2025 16:50 | GDR | Genedrive revenue rises but loss widens as it seeks US boost | Alliance |
27.03.2025 15:30 | GDR | RetailBook Offer | RNS |
27.03.2025 15:29 | GDR | Half-year Report | RNS |
27.03.2025 15:28 | GDR | Equity Fundraise | RNS |
17.03.2025 13:47 | GDR | Genedrive hails Scottish government investment to support testing | Alliance |
17.03.2025 11:04 | GDR | Scottish Government testing programme investment | RNS |
14.03.2025 07:00 | GDR | CYP2C19-ID Kit adopted for routine clinical use | RNS |
30.12.2024 11:54 | GDR | Result of AGM | RNS |
27.12.2024 11:51 | GDR | Genedrive shares rise on positive results for genetic testing kit | Alliance |
27.12.2024 10:25 | ESO, PEEL, NTOG | AIM WINNERS & LOSERS: Genedrive hails positive test kit trial results | Alliance |
27.12.2024 07:00 | GDR | Genedrive® CYP2C19-ID Kit performance published | RNS |
23.12.2024 15:28 | TM1, ZAM, HAYD | UK shareholder meetings calendar - next 7 days | Alliance |
20.12.2024 12:16 | GDR | Grant of Options | RNS |
20.12.2024 12:12 | GDR | Director/PDMR Shareholding | RNS |
05.12.2024 15:00 | GDR | Posting of annual report and notice of AGM | RNS |
29.11.2024 13:00 | GDR | Block listing returns | RNS |
29.11.2024 10:56 | BOD, GDR, PEEL | AIM WINNERS & LOSERS: Botswana Diamonds shines; Peel Hunt slips | Alliance |
29.11.2024 10:18 | GDR | Genedrive annual loss widens due to increased expenses | Alliance |
29.11.2024 07:00 | GDR | Final Results | RNS |
22.11.2024 11:35 | PEEL, GDR, CPX | UK earnings, trading statements calendar - next 7 days | Alliance |
22.11.2024 07:00 | GDR | Notice of Results | RNS |
21.11.2024 11:06 | GDR | NIHR and OLS Funding Package | RNS |
05.11.2024 10:53 | GDR | Department for Business and Trade feature | Reach |
04.11.2024 13:29 | GDR | Scottish Health Technology Group publications | RNS |
21.10.2024 15:22 | GDR | Director Declaration | RNS |
15.08.2024 10:39 | GDR | Director/PDMR Shareholding | RNS |
12.08.2024 07:00 | GDR | First UK commercial sales of the CYP2C19-ID Kit | RNS |
06.08.2024 14:36 | GDR | Genedrive CEO leaves after less than a year; promotes CSO Miele to CEO | Alliance |
06.08.2024 07:00 | GDR | Directorate Change | RNS |
31.07.2024 11:33 | UKOG, GDR | AIM WINNERS & LOSERS: Genedrive gets UK CYP2C19-ID test boost | Alliance |
31.07.2024 07:00 | GDR | NICE recommends CYP2C19-ID Kit in final guidance | RNS |